Ildstad Suzanne

CIK 00018458221 companyLOUISVILLE, KY

SEC Profile

Transactions

Companies

Filings

CIK

0001845822

Recent Transactions

32 trades

Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-14$2.49/sh−12,942→ 3,771,392 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2023-06-13+20,500→ 20,500 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-13$2.56/sh−14,208→ 3,784,334 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-12$2.59/sh−16,870→ 3,798,542 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-09$2.46/sh−25,419→ 3,815,412 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-08$2.48/sh−40,642→ 3,840,831 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-07$2.39/sh−75,001→ 3,881,473 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-06$2.53/sh−25,549→ 2,756,474 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-05$2.52/sh−7,841→ 2,782,023 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-02$2.50/sh−15,818→ 2,789,864 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-06-01$2.56/sh−15,713→ 2,805,682 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-04-21$2.35/sh−15,004→ 2,821,395 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-04-20$2.33/sh−46,990→ 2,836,399 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-04-19$2.16/sh−21,753→ 2,883,389 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-04-18$2.15/sh−49,211→ 2,905,142 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-04-17$2.14/sh−99,771→ 2,954,353 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-03-17$2.06/sh−10,436→ 3,054,124 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-03-17$2.06/sh−10,436→ 3,054,124 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-03-03$2.06/sh−6,806→ 3,064,560 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-03-03$2.06/sh−6,806→ 3,064,560 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-03-01$2.05/sh−29→ 3,071,366 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-03-01$2.05/sh−29→ 3,071,366 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-02-21$2.05/sh−3,500→ 3,071,395 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-02-21$2.05/sh−3,500→ 3,071,395 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-02-17$2.05/sh−3,612→ 3,074,895 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-02-17$2.05/sh−3,612→ 3,074,895 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-02-16$2.06/sh−2,939→ 3,078,507 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2023-02-16$2.06/sh−2,939→ 3,078,507 total
Sale
Tourmaline Bio, Inc.$TRML
Common Stock
2022-08-22$2.80/sh−525,000→ 3,081,446 total
Award
Tourmaline Bio, Inc.$TRML
Stock Option (Right to Buy)
2022-02-01+150,000→ 150,000 total
Gift
Tourmaline Bio, Inc.$TRML
Common Stock
2021-11-17−1,200,000→ 3,606,446 total
Gift
Tourmaline Bio, Inc.$TRML
Common Stock
2021-11-17+1,200,000→ 1,200,000 total

Companies

Tourmaline Bio, Inc.
Director, Chief Scientific Officer, 10% Owner
$TRML

Recent Filings

Address

C/O TALARIS THERAPEUTICS, INC. 570 S. PRESTON STREET

LOUISVILLE, KY, 40202

View on SEC.gov